Otonomy to Present at the Needham Virtual Healthcare Conference

SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the 20th Annual Needham Virtual Healthcare Conference. David A. Weber, Ph.D., president and CEO of Otonomy, will present a company overview on Tuesday, April 13, 2021 at 4:30 p.m. ET (1:30 p.m. PT).

A live audio webcast of the presentation will be available through the Events page of the company's website (www.otonomy.com). An archived webcast of the presentation will also be available on the same web page shortly after the live event.

About OtonomyOtonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media InquiriesSpectrum ScienceChloé-Anne RamseyVice President404.865.3601[email protected]

Investor InquiriesWestwicke ICRRobert H. UhlManaging Director858.356.5932[email protected]

You May Also Be Interested In

• Correction: Solutions30, through its subsidiary Unit-T, is selected to support Fluvius in their ´Energy Grid upgrade program´ in Flanders with a 5-year contract, extendable for another 3 years
• Salary.com Celebrates 25 Years of Innovation
• Mullen Group Ltd. Announces Declaration of Monthly Dividend